Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Dec 29, 2019 11:34pm
106 Views
Post# 30500148

RE:3 cent SP target and lack of response

RE:3 cent SP target and lack of responseYes, best of all to the real investors of EDT not your "friends"  who are actually your alter egos. This is so tiring! Acting like you aren't one and the same! Split personalities can be managed!!! Take your meds or why else would you overburden us with you repetitious posts (albeit somewhat informative but then you post your nonsensical ones ; about =)
Looking forward to 2020 where events/practical wishes and updates occur:
1. Update on the # of sites that are recruting (and how many patients).
2. Will the need for more money to complete trial require:
   a) insider financing ? (easily done since they already own most of the shares!!
   b) 3rd party to fund as an easy entry into being exposed to the upside potential
   c) spin off Dialco/DIMI/SAMI to raise funds?
           - or use Dialco to enter the US exchanges via ..... hmm, how could that be done?
3. Get on American Exchange (see #2)
      - our new CFO is said to have lots of experience with this sort of activity!!!???

Why does the company's website shows in the Investor Overview that there is a $3B market and in the Investor Presentation it shows a $1.5B market

Bullboard Posts